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epair of the
ongenitally Bicuspid
egurgitant Aortic Valve
Strategic Advance*
effrey S. Borer, MD, FACC,
eonard N. Girardi, MD
ew York, New York
icuspid aortic valve (BAV) is a common congenital abnor-
ality, affecting 1% to 2% of live births and found in
pproximately 4,000,000 persons in the U.S. (1). BAV
esults in severe aortic regurgitation (AR) in almost 20% of
hose affected (2); it is the primary cause of AR among persons
ge65 years. When AR is severe and consequent symptoms
r specific asymptomatic left ventricular or ascending aortic
lterations develop (3), the generally accepted response is
alve replacement with or without replacement/repair of
ome portion of the ascending aorta. Surgery for BAV
ommonly is required during the fourth through sixth
ecades of life. Long-term survival after surgery for AR now
s reasonably favorable (4–6), limited primarily by pre-
perative myocardial function rather than by limitations
See page 40
mposed by surgery (7). Nonetheless, aortic valve replace-
ent is a suboptimal solution for patients with AR from
AV: the operated patient faces a prolonged interval of
ubstantial risk for pathological bleeding if the prosthesis is
n anticoagulation-requiring mechanical device (despite rel-
tive freedom from reoperation [6]), or late prosthesis
ailure and reoperation if a nonanticoagulation-requiring
ioprosthesis is employed (6), even if allografting is selected
8). When corrected for age at operation, cardiac function
nd comorbidities, late survival (and thromboembolism risk)
s similar with bioprosthetic and anticoagulated mechanical
alves (5,6). Various valve repair procedures (tailored to the
pecific characteristics of congenitally deformed valves) long
ave provided alternatives (9). While repairs have been
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From The Howard Gilman Institute for Valvular Heart Diseases, Cardiovasculars
athophysiology Unit, and the Department of Cardiothoracic Surgery, Weill Cornell
edical College, New York, New York.ighly successful and reasonably durable for congenital
itral leaflet prolapse (10), BAV repairs generally have
ailed earlier than bioprostheses (11), rendering current
pproaches of questionable utility. One reason may be the
elatively unforgiving mechanical demands of BAV archi-
ecture and tissue quality, mandating refinements in surgical
echniques; another may be inadequate criteria to identify
alves likely to be durably repaired with current techniques.
n this issue of the Journal, Pettersson et al. (12) propose a
ew solution to the latter problem. These authors prospec-
ively employed a description system using intracardiac
uantitative echocardiography (variably supplemented by
re-operative computerized tomographic and magnetic res-
nance imaging) to characterize deformed valves by cusp
athology (redundancy, restriction, cusp height to indicate
ikely adequacy of coaptatation, mobility/pliability, thick-
ess, integrity), commissure variations (fusion, splaying,
ttachment site, and alignment), and root morphology
septal hypertrophy, septal integrity, annular size, sinus and
inotubular junction dimensions, and ascending aorta di-
ension). Decisions about reparability of any valve compo-
ent were based on the surgeon’s subjective interpretation of
hese data; each reparable echocardiographic characteristic
as corrected with a maneuver specific for that finding.
fter repair, intraoperative echocardiographic characteris-
ics were identified that most closely tracked with surgical
uccess/failure (defined by valve function and need for
eoperation) during an average 2-year follow-up.
Others have reported objective criteria for appropriate
election of valves for repair (including cusp or commissural
hickening and cusp calcification [13]) or for selecting repair
echnique (e.g., effective cusp height [14]). The study of
ettersson et al. (12) adds importantly to these earlier
fforts, first, by employing a particularly comprehensive and
ystematic approach. Secondly, these authors include a
easure of tissue quality, a “tissue normality index” of cusp
liability, and of residual transvalvular gradient, together
ith anatomic descriptors (including a new morphologic
coaptation deficiency index”). Indeed, deficient tissue qual-
ty probably was involved in the 4 early repair failures,
hough not clearly predicted by the echocardiographic
easures used in this small series.
Although Pettersson et al. (12) used their system to
valuate appropriateness of repair and to select technical
aneuvers to be used during the procedure, the study was
ndertaken primarily to identify intraoperative measures
nd surgical responses most closely associated with success-
ul repair. As such, its conclusions inherently are limited by
ts small size, few adverse events, and relatively short
ollow-up. More importantly, the study is descriptive and
bservational; its design does not permit assessment of the
elative utility of selection criteria based on the objective
easurements. Indeed, precise criteria employed to elimi-
ate repair as an option, or judged sufficient to require a
pecific technical repair maneuver, are not defined, limiting
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July 1, 2008:50–1 Editorial Commentpplication of these data by other surgeons and suggesting
ependence on subjective judgment. In addition, though
oot characteristics did not importantly predict outcome,
his may have resulted, in part, from patient selection,
uggesting the need for further assessment of the contribu-
ion of root pathology to selection of repair techniques and
heir success. Alternatively, the authors’ relatively low
hreshold for associated root surgery (aortic dimension of 40
m, rather than the generally accepted 45 mm [3]) may
ave precluded problems that otherwise might have arisen.
inally, more information relating pre-operative to intraop-
rative echocardiographic findings would have been useful:
re-operative identification of poor candidates for repair
ould beneficially inform discussions with patients.
Randomized trials of surgical strategies, required for optimal
valuation of the approach of Pettersson et al. (12), are highly
esirable, but very difficult in practice. Moreover, given the
iological variability among valves and tissues, some indi-
idual judgment always will be needed. However, judgment
ight be usefully guided by comprehensive tissue charac-
erization (composition, cell/molecular biology), as inferable
rom results with authors’ tissue normality index, though
his index, itself, was not optimally predictive; authors
issed a useful opportunity to characterize tissue from
urgical wastes (shaved cusps, resected raphe) or from root
iopsies, and so on. Recent observations concerning the
otential importance of deficiencies of microfibrillar pro-
eins (2) and of endothelial nitric oxide synthase expression
15) in the pathogenesis of BAV suggest that comprehen-
ive tissue characterization may contribute importantly to
ptimizing approaches to BAV surgery.
Limitations notwithstanding, Pettersson et al. (12) have
rovided a valuable contribution. Their data support sys-
ematic segmental characterization of valve and outflow
ract morphology for technical decisions during BAV sur-
ery and, preliminarily, suggest that patients with coapta-
ion or pliability deficiencies probably should not undergo
AV repair. Further data are needed to define appropriate
pplication, and ultimate utility, of this strategy.
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